SCHEMBL29434375

SCHEMBL29434375

COC(=O)[C@H]1C(=O)NC[C@@H]1c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.53
F2RL1 P55085 7/20 0.52
CYP3A4 P08684 2/20 0.52
CYP2C9 P11712 2/20 0.52
HTT P42858 2/20 0.52
ALDH1A1 P00352 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C19 P33261 1/20 0.52
CYP2D6 P10635 1/20 0.51
PDE4A P27815 1/20 0.50
PDE4B Q07343 1/20 0.50
PDE4C Q08493 1/20 0.50
PDE4D Q08499 1/20 0.50
HTR2A P28223 1/20 0.49
HRH1 P35367 1/20 0.49
ATM Q13315 1/20 0.49
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
MEN1 O00255 1/20 0.47
POLB P06746 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11863807 1.00 KDM4E (0.53) KDM4EF2RL1CYP3A4CYP2C9HTT
SCHEMBL19857212 1.00 KDM4E (0.53) KDM4EF2RL1CYP3A4CYP2C9HTT
SCHEMBL16785349 1.00 KDM4E (0.53) KDM4EF2RL1CYP3A4CYP2C9HTT
SCHEMBL4539386 0.87 ATM (0.48) ATMMEN1POLBKMT2ASLC6A3
SCHEMBL18106605 0.85 PDE4A (0.54) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL16785489 0.85 PDE4A (0.54) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL18117707 0.85 PDE4A (0.54) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL20177924 0.85 SLC6A3 (0.55) PDE4APDE4BPDE4CPDE4DSLC6A3
SCHEMBL19559436 0.85 PDE4A (0.54) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL29434235 0.85 PDE4A (0.54) ALDH1A1PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11261155-B2 Urea derivative or pharmacologically acceptable salt thereof KYORIN PHARMACEUTICAL CO., LTD. (JP) 2022-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11261155-B2 Urea derivative or pharmacologically acceptable salt thereof FPR1, FPR2, FPR3 KDM4E 4640/4885F2RL1 115/4885CYP3A4 3084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.